相关实验视频

Updated: Jul 19, 2026

Embryo Microinjection Techniques for Efficient Site-Specific Mutagenesis in Culex quinquefasciatus
05:59

Embryo Microinjection Techniques for Efficient Site-Specific Mutagenesis in Culex quinquefasciatus

Published on: May 24, 2020

昆虫激素作为子堕胎剂

D L Denlinger

    Nature
    |January 31, 1975
    PubMed
    概括

    No abstract available in PubMed .

    更多相关视频

    Preparing and Injecting Embryos of Culex Mosquitoes to Generate Null Mutations using CRISPR/Cas9
    07:45

    Preparing and Injecting Embryos of Culex Mosquitoes to Generate Null Mutations using CRISPR/Cas9

    Published on: September 10, 2020

    Mouse Round Spermatid Injection
    08:41

    Mouse Round Spermatid Injection

    Published on: January 26, 2024

    相关实验视频

    Last Updated: Jul 19, 2026

    Embryo Microinjection Techniques for Efficient Site-Specific Mutagenesis in Culex quinquefasciatus
    05:59

    Embryo Microinjection Techniques for Efficient Site-Specific Mutagenesis in Culex quinquefasciatus

    Published on: May 24, 2020

    Preparing and Injecting Embryos of Culex Mosquitoes to Generate Null Mutations using CRISPR/Cas9
    07:45

    Preparing and Injecting Embryos of Culex Mosquitoes to Generate Null Mutations using CRISPR/Cas9

    Published on: September 10, 2020

    Mouse Round Spermatid Injection
    08:41

    Mouse Round Spermatid Injection

    Published on: January 26, 2024

    相关概念视频

    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Intrauterine Drug Delivery Systems01:21

    Intrauterine Drug Delivery Systems

    Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
    JoVE
    关于 JoVE
    概览领导团队博客JoVE 帮助中心
    作者
    出版流程编辑委员会范围与政策同行评审常见问题投稿
    图书馆员
    用户评价订阅访问资源图书馆顾问委员会常见问题
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
    使用条款与条件
    隐私政策
    政策
    Jove
    Visualize
    联系我们